Manideepa Maji: IV Iron Safety in Heart Failure
Manideepa Maji, NIHR Academic Clinical Fellow- Hematology at Hull York Medical School, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in BMJ Journals, adding:
“Intravenous iron in heart failure: fewer hospitalisations, but what about infection risk?
Our systematic review and meta-analysis is now published in BMJ Open Heart.
Across 18 independent trial cohorts, we found:
- 22 percent lower rate of heart failure hospitalisations.
- No clear increase in infection or serious infection, although evidence certainty was low.
The infection findings are reassuring, but we need more consistent safety reporting.
Thank you to all my co-authors!”
Title: Infection risk and clinical outcomes with intravenous iron in adults with heart failure and iron deficiency: a systematic review and meta-analysis of randomised controlled trials
Authors: Saikat Mandal, Joyisa Deb ,Vaidehi Prasanth, Aswin K Mohan, Justin Jose, So Ahng Yoon, Manideepa Maji, Asmita Goswami, Anindya Mukherjee, Arkadeep Dhali
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian